| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.10B | $3.64B | $3.28B |
| YoY Revenue Growth % | -15.1% | +11.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $392.0M | $851.0M | $383.0M |
| Operating Margin % | 12.7% | 23.4% | 11.7% |
| Net Income (GAAP) | -$85.0M | $375.0M | -$76.0M |
| EBITDA (Normalized) | $478.4M | $965.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $289.0M | $751.0M | $648.0M |
| Capital Expenditures (CapEx) | $108.0M | $143.0M | — |
| Free Cash Flow (FCF) | $181.0M | $608.0M | $648.0M |
| FCF Margin % | 5.8% | 16.7% | 19.8% |
| Return on Invested Capital (ROIC %) | 4.1% | 8.7% | — |
| Cash & Short-Term Equivalents | $368.0M | $135.0M | — |
| Total Debt (Short + Long Term) | $5.74B | $5.60B | — |
| Total Stockholders' Equity | $2.15B | $2.28B | — |